苑东生物：2025年第三季度归属于上市公司股东的净利润同比增长18.52%

Core Insights - The company reported a revenue of 364,685,045.87 yuan for the third quarter of 2025, representing a year-on-year decline of 1.55% [1] - The net profit attributable to shareholders of the listed company was 83,590,556.58 yuan, showing a year-on-year increase of 18.52% [1] Financial Performance - Revenue for Q3 2025: 364.69 million yuan, down 1.55% year-on-year [1] - Net profit for Q3 2025: 83.59 million yuan, up 18.52% year-on-year [1]